Dosificación del factor X en el control de la terapia anticoagulante oral
Abstract
Se estudia la concentración de F X plasmático en un grupo de 29 pacientes con antece dentes de TV, sometidos a tratamiento anticoagulante oral con Pelentán y Cloratrombón. Se clasifican en dos grupos según el tiempo de protrombina: un grupo dentro del rango terapéutico y el otro grupo fuera de él. Se comparan ambos grupos empleando para ello la prueba de Mann y Whitney, obteniendo diferencias estadísticamente significativas para p<0,01. Se comentan resultados obtenidos por otros autores y se propone el estudio de la actividad inhibidora del F Xa como complemento del tiempo de protrombina en el control de la terapia anticoagulante oral.Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
